Jeremy D. Henson

October 14, 2022

Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain

Abstract This pilot study aimed to assess the safety, tolerability, pharmacokinetics and exploratory analgesic effect of a novel water-soluble oro-buccal…

July 7, 2022

Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions

Abstract Combination tetrahydrocannabinol (THC)/cannabidiol (CBD) medicines or CBD-only medicines are prospective treatments for chronic pain, stress, anxiety, depression, and insomnia.…

December 14, 2021

Enhancing Endocannabinoid Control of Stress with Cannabidiol

Abstract The stress response is a well-defined physiological function activated frequently by life events. However, sometimes the stress response can…